PROCEPT BioRobotics Corporation Common Stock (PRCT)

Price$27.83

Value ScoreD

Growth ScoreA

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-20.08%

Price vs S&P 500 (4W)9.58%

VGM Score56.44

Market Capitalization$1.58B

All Metrics

Book Value / Share (Quarterly)$6.11

P/TBV (Annual)4.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)60.14%

Cash Flow / Share (Quarterly)$-1.42

Price vs S&P 500 (YTD)-19.70%

Gross Margin (TTM)63.97%

Net Profit Margin (TTM)-31.82%

EPS (TTM)$-1.83

10-Day Avg Trading Volume1.07M

EPS Excl Extra (TTM)$-1.83

Revenue Growth (5Y)109.03%

EPS (Annual)$-1.72

ROI (Annual)-22.89%

Gross Margin (Annual)63.70%

Net Profit Margin (5Y Avg)-87.86%

Cash / Share (Quarterly)$4.32

Revenue Growth QoQ (YoY)20.20%

ROA (Last FY)-18.81%

Revenue Growth TTM (YoY)29.26%

EBITD / Share (TTM)$-1.83

ROE (5Y Avg)-30.64%

Operating Margin (TTM)-33.86%

Cash Flow / Share (Annual)$-1.04

P/B Ratio4.56x

P/B Ratio (Quarterly)4.06x

Net Income / Employee (Annual)$-107,600

EV / Revenue (TTM)4.32x

Net Interest Coverage (TTM)-26.49x

ROA (TTM)-20.29%

EPS Incl Extra (Annual)$-1.72

Current Ratio (Annual)6.85x

Quick Ratio (Quarterly)5.37x

3-Month Avg Trading Volume1.59M

52-Week Price Return-57.22%

Revenue / Employee (TTM)$362,600

Tangible BV / Share (Quarterly)$6.10

P/S Ratio (Annual)5.14x

Asset Turnover (Annual)0.61x

52-Week High$66.85

Operating Margin (5Y Avg)-85.20%

EPS Excl Extra (Annual)$-1.72

CapEx CAGR (5Y)109.83%

26-Week Price Return-12.15%

Quick Ratio (Annual)5.62x

13-Week Price Return9.78%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)6.73x

Enterprise Value$1.39B

Revenue / Share Growth (5Y)97.92%

Asset Turnover (TTM)0.64x

Revenue / Employee (Annual)$346,900

Inventory Turnover (Annual)1.76x

Pretax Margin (Annual)-30.96%

Cash / Share (Annual)$5.09

3-Month Return Std Dev68.79%

Gross Margin (5Y Avg)54.49%

Net Income / Employee (TTM)$-115,400

ROE (Last FY)-26.12%

Net Interest Coverage (Annual)-35.41x

EPS Basic Excl Extra (Annual)$-1.72

Receivables Turnover (TTM)3.67x

Total Debt / Equity (Quarterly)0.15x

EPS Incl Extra (TTM)$-1.83

Receivables Turnover (Annual)3.69x

ROI (TTM)-24.31%

P/S Ratio (TTM)4.92x

Pretax Margin (5Y Avg)-87.85%

Revenue / Share (Annual)$5.55

Tangible BV / Share (Annual)$6.48

Price vs S&P 500 (52W)-81.58%

Year-to-Date Return-11.54%

5-Day Price Return-0.11%

EPS Normalized (Annual)$-1.72

ROA (5Y Avg)-21.61%

Net Profit Margin (Annual)-31.02%

Month-to-Date Return5.70%

Cash Flow / Share (TTM)$-2.26

EBITD / Share (Annual)$-1.75

Operating Margin (Annual)-33.71%

LT Debt / Equity (Annual)0.14x

ROI (5Y Avg)-25.78%

LT Debt / Equity (Quarterly)0.15x

EPS Basic Excl Extra (TTM)$-1.83

P/TBV (Quarterly)4.06x

P/B Ratio (Annual)4.80x

Inventory Turnover (TTM)1.66x

Pretax Margin (TTM)-31.78%

Book Value / Share (Annual)$6.50

Price vs S&P 500 (13W)1.53%

Beta0.85x

Revenue / Share (TTM)$5.70

ROE (TTM)-27.70%

52-Week Low$19.35

vGradeD

gGradeA

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.56est. -0.57

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.10

3.95

3.90

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
PRCTPROCEPT BioRobotics Corporation Common Stock	D	A	C	$27.83
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

PROCEPT BioRobotics develops, manufactures, and sells image-guided robotic surgical systems for minimally invasive urologic procedures. The company's AquaBeam and HYDROS platforms primarily address the benign prostatic hyperplasia market, with revenue concentrated in the United States and expanding international operations.